Literature DB >> 9030703

Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer disease.

K Chandrasekaran1, K Hatanpää, S I Rapoport, D R Brady.   

Abstract

We recently reported 50% decreases in mRNA levels of mitochondrial DNA (mtDNA)-encoded cytochrome oxidase (COX) subunits I and III in Alzheimer disease (AD) brains. The decreases were observed in an association neocortical region (midtemporal cortex) affected in AD, but not in the primary motor cortex unaffected in AD. To investigate whether the decreases are specific to mtDNA-encoded mRNA, we extended this analysis to nuclear DNA (nDNA)-encoded subunits of mitochondrial enzymes of oxidative phosphorylation (OXPHOS). Brains from five AD patients showed 50-60% decreases in mRNA levels of nDNA-encoded subunit IV of COX and the beta-subunit of the F0F1-ATP synthase in midtemporal cortex compared with mRNA levels from midtemporal cortex of control brains. In contrast, these mRNAs were not reduced in primary motor cortices of the AD brains. The amount of nDNA-encoded beta-actin mRNA and the amount of 28S rRNA were not altered in either region of the AD brain. The results suggest that coordinated decreases in expression of mitochondrial and nuclear genes occur in association cortex of AD brains and are a consequence of reduced neuronal activity and downregulation of OXPHOS machinery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9030703     DOI: 10.1016/s0169-328x(96)00191-x

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  32 in total

1.  The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease.

Authors:  M Y Aksenov; H M Tucker; P Nair; M V Aksenova; D A Butterfield; S Estus; W R Markesbery
Journal:  Neurochem Res       Date:  1999-06       Impact factor: 3.996

2.  Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.

Authors:  Fabio Di Domenico; Rukhsana Sultana; Eugenio Barone; Marzia Perluigi; Chiara Cini; Cesare Mancuso; Jian Cai; William M Pierce; D Allan Butterfield
Journal:  J Proteomics       Date:  2011-04-13       Impact factor: 4.044

3.  Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons.

Authors:  Winnie S Liang; Eric M Reiman; Jon Valla; Travis Dunckley; Thomas G Beach; Andrew Grover; Tracey L Niedzielko; Lonnie E Schneider; Diego Mastroeni; Richard Caselli; Walter Kukull; John C Morris; Christine M Hulette; Donald Schmechel; Joseph Rogers; Dietrich A Stephan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

Review 4.  ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.

Authors:  Sangjin Hong; Peter L Pedersen
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

5.  Mitochondrial Proteome Changes Correlating with β-Amyloid Accumulation.

Authors:  Katalin Völgyi; Krisztina Háden; Viktor Kis; Péter Gulyássy; Kata Badics; Balázs András Györffy; Attila Simor; Zoltán Szabó; Tamás Janáky; László Drahos; Árpád Dobolyi; Botond Penke; Gábor Juhász; Katalin Adrienna Kékesi
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

Review 6.  Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?

Authors:  P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2012-09-17

Review 7.  Advances and challenges in the prevention and treatment of Alzheimer's disease.

Authors:  R Diaz Brinton; R S Yamazaki
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

Review 8.  Diabetes and Cognitive Impairment.

Authors:  Lindsay A Zilliox; Krish Chadrasekaran; Justin Y Kwan; James W Russell
Journal:  Curr Diab Rep       Date:  2016-09       Impact factor: 4.810

9.  Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage.

Authors:  Maria Manczak; Byung S Park; Youngsin Jung; P Hemachandra Reddy
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

10.  Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication.

Authors:  Pinar E Coskun; M Flint Beal; Douglas C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.